Skip to content
  • 6,946 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Special notice

Justification & Approval for Sole Source: Human induced pluripotent stem cell-derived Macrophages (hiPSC-MACs)

75F40124Q122639J-A

Food and Drug Administration, FDA Office of Acq Grant SVCS. Research and Development in Biotechnology (except Nanobiotechnology).

18 open like this View on SAM.gov Markdown

Response deadline

March 25, 2024 at 11:00 AM EDT

Closed 952 days ago. Posted March 19, 2024. Scheduled to archive April 9, 2024.

Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities

This one closed in 2024

18 like it are open now in research and development in biotechnology (except nanobiotechnology)

All 18 open in research and development in biotechnology (except nanobiotechnology)

Description

As published on SAM.gov.

See J&A for Sole Source procurement for Human induced pluripotent stem cell-derived Macrophages (hiPSC-MACs). See also associated Intent to Sole Source and RFQ under notice #: 75F40124Q122639

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. March 19, 2024

    Special notice

    Due March 25, 2024 at 11:00 AM EDT. SAM.gov, notice d94e793dfb1a4759b1dba1362f42e097

Points of contact